Live birth following the first mutation specific pre-implantation genetic diagnosis for haemophilia A

Summary

Haemophilia A is an X-linked, recessive, inherited bleeding disorder which affects 1 in 5000 males born worldwide. It is caused by mutations in the FactorVIII (F8) gene on chromosome Xq28. We describe for the first time two mutation specific, single cell protocols for pre-implantation genetic diagnosis (PGD) of haemophilia A that enable the selection of both male and female unaffected embryos. This approach offers an alternative to sexing, frequently used for X-linked disorders, that results in the discarding of all male embryos including the 50% that would have been normal. Two families witha history of severe haemophilia A requested carrier diagnosis and subsequently proceeded to PGD. The mutation in family1 isa single nucleotide substitution c. 5953C>T, R1966X in exon 18 and in family 2, c. 5122C>T, R1689C in exon 14 of the F8 gene. Amplification efficiency was compared between distilled water and SDS/proteinase K cell lysis (98.0%, 96/98 and 80%, 112/140 respectively) using 238 single lymphocytes. Blastomeres from spare IVF cleavage-stage embryos donated for research showed amplification efficiencies of 83.3% (45/54) for the R1966X and 92.9% (13/14) for the R1689C mutations. The rate of allele dropout (ADO) on heterozygous lymphocytes was 1.1% (1/93) for R1966X and 5.94% (6/101) for R1689C mutations. A single PGD treatment cycle for family1 resulted in two embryos for transfer but these failed to implant. However, with family 2, two embryos were transferred to the uterus on day 4 resulting in a successful singleton pregnancy and subsequent live birth of a normal non-carrier female.

Keywords

FVIII - haemophilia A - inherited bleeding disorder - preimplantation genetic diagnosis

• References

• 1 Tuddenham EGD, Schwaab R, Seehafer J. et al. Haemophilia A: database of nucleotide substitutions, deletions, insertions and rearrangements of the factor VIII gene. Nucleic Acids Res 1994; 22: 3511-33.
• 2 Antonarakis SE, Kazazian HH, Tuddenham EGD. Molecular etiology of factor VIII deficiency in haemophilia A. Hum Mutat 1995; 05: 1-22.
• 3 Tantravahi U, Murty VV, Jhanwar SC. et al. Physical mapping of the factor VIII gene proximal to two polymorphic DNA probes in human chromosome band Xq28 implications for factor VIII gene segregation analysis. Cytogenet Cell Genet 1986; 42: 75-9.
• 4 Lakich S, Kazazian Jr HH, Antonarakis SE. et al. Inversions disrupting the factor VIII gene are a common cause of severe haemophilia A. Nature Genetics 1993; 05: 236-41.
• 5 Naylor JA, Green PM, Pizza CR. et al. Analysis of factor VIII mRNA reveals defects in every one of 28 haemophilia A patients. Hum. Mol Genet 1993; 02: 11-7.
• 6 Bagnall RD, Waseem N, Green PM. et al. Recurrent inversion breaking intron 1 of the factor VIII gene is a frequent cause of severe hemophilia A. Blood 2002; 99: 168-74.
• 7 Hoyer LW. Haemophilia A. N Engl J Med 1994; 330: 38-47.
• 8 Lalloz MRA, Schwaab R, McVey JH. et al. Haemophilia A diagnosis by simultaneous analysis of two variable dinucleotide tandem repeats within the factor VIII gene. Br J Haematol 1994; 86: 804-9.
• 9 Lavery SA, Aurell R, Turner C. et al. Preimplantation genetic diagnosis: patients experiences and attitudes. Hum Reprod 2002; 09: 2464-7.
• 10 Handyside AH, Pattinson JK, Penketh RJ. et al. Biopsy of human preimplantation embryos and sexing by DNA amplification. Lancet 1989; 01: 347-9.
• 11 Sütterlin M, Abou PSleiman, Onadim Z. et al. Single cell detection of inherited retinoblastoma predisposition. Prenat. Diagn 1999; 19: 1231-6.
• 12 Piyamongkol W, Bermudez MG, Harper JC. et al. Detailed investigation of factors influencing amplification efficiency and allele drop-out in single cell PCR: implications for preimplantation genetic diagnosis. Mol Hum Reprod 2003; 09: 411-20.
• 13 Jeffreys AJ, Wilson V, Neumann R. et al. Amplification of human minisatellites by the polymerase chain reaction: towards fingerprinting of single cells. Nucleic Acid Res 1988; 16: 10953-71.
• 14 Holding C, Bentley D, Roberts R. et al. Development and validation of laboratory procedures for preimplantation diagnosis of Duchenne muscular dystrophy. J Med Genet 1993; 30: 903-9.
• 15 Handyside AH, Kontogianni EH, Hardy K. et al. Pregnancies from biopsied human preimplantation embryos sexed by Y-specific DNA amplification. Nature 1990; 344: 768-70.
• 16 Gigarel N, Frydman N, Burlet P. et al. Single cell co-amplification of polymorphic markers for the indirect preimplantation genetic diagnosis of haemophilia A, X-linked adrenoleukodystrophy, X-linked hydrocephalus and incontinentia pigmenti loci on Xq28. Hum Genet 2004; 114: 298-305.
• 17 Fiorentino F, Magli MC, Podini D. et al. The minisequencing method: an alternative strategy for preimplantation genetic diagnosis of single gene disorders. Mol Hum Reprod 2003; 09: 399-410.
• 18 Ray PF, Handyside AH. Increasing the denaturation temperature during the first cycles of amplification reduces allele dropout from single cells for preimplantation genetic diagnosis. Mol Hum Reprod 1996; 02: 213-8.
• 19 El-Hashemite N, Delhanty JDA. A technique for eliminating allele specific amplification failure during DNA amplification of heterozygous cells for preimplantation diagnosis. Mol Hum Reprod 1997; 03: 975-8.
• 20 Sermon K, Lissens W, Nagy ZP. et al. Simultaneous amplification of the two most frequent mutations of infantile Tay-Sachs Disease in single blastomeres. Hum Reprod 1995; 10: 2214-7.
• 21 Gitlin SA, Lanzendorf SE, Gibbson WE. Polymerase chain reaction amplification specificity: Incidence of allele dropout using different DNA preparation methods for heterozygous single cells. J Assist Reprod Genet 1996; 13: 107-11.
• 22 Findikli N, Kahraman S, Kumtepe Y. et al. Assessment of DNA fragmentation and aneuploidy on poor quality human embryos. Reproductive Biomedicine online 2003; 08: 196-206.
• 23 Munné S, Cohen J. Chromosome abnormalities in human embryos. Human Reproduction Update 1998; 04: 842-55.
• 24 Lambert NC, Dennis YMLo, Erickson TD. et al. Male microchimerism in healthy women with scleroderma: cells or circulating DNA? A quantitative answer. Blood 2002; 100: 2845-51.
• 25 Adams KM, Lambert NC, Heimfeld S. et al. Male DNA in female apheresis and CD34-enriched products. Blood 2003; 102: 3845-7.
• 26 Fischer K, Van Den Berg M. Prophylaxis for severe haemophilia: clinical and economical issues. Haemophilia 2003; 09: 376-81.